Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,024 public trials 710 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

NCT02941367

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Investigational Site Number 356005 Ahmedabad, India
  • Investigational Site Number 356002 Bangalore, India
  • Investigational Site Number 356015 Bangalore, India
  • Investigational Site Number 356008 Bangalore, India
View all 16 locations
View Trial Details
Completed

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy

NCT02855684

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 1560039 Beijing, China
  • Investigational Site Number 1560001 Beijing, China
  • Investigational Site Number 1560017 Beijing, China
  • Investigational Site Number 1560003 Beijing, China
View all 54 locations
View Trial Details
Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

NCT03529123

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 01 Bangalore, India
  • Investigational Site Number 012 Belagavi, India
  • Investigational Site Number 013 Chennai, India
  • Investigational Site Number 017 Coimbatore, India
View all 13 locations
View Trial Details
Completed

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin

NCT02967211

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Investigational Site Number 076-001 Curitiba, Brazil
  • Investigational Site Number 076008 Fortaleza, Brazil
  • Investigational Site Number 076004 Fortaleza, Brazil
  • Investigational Site Number 076009 Rio de Janeiro, Brazil
View all 118 locations
View Trial Details

Related conditions